84 results
·
16ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: FDA Class 3
×
Pump, Infusion, Implanted, Programmable
FDA Pre-Market Approval
FDA Class 3
·Implantable System for Remodulin
Test, Anti-Tumor Cell Susceptibility
FDA Pre-Market Approval
FDA Class 3
·BARTELS CHEMORESPONSE ASSAY
Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·SYNERGYXD Everolimus-Eluting Platinum Chromium Coronary Stent System, SYNERGY MEGATRON Everolimus-Eluting Platinum Chr
Coronary Drug-Eluting Stent
FDA Pre-Market Approval
FDA Class 3
·SYNERGY XD Everolimus Eluting Platinum Chromium Coronary Stent System and SYNERGY SHIELD Everolimus Eluting Platinum Chr